Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes
- 9 June 2000
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 159 (7) , 483-488
Abstract
The pharmacokinetics of the novel, rapid-acting insulin aspart were compared with those of soluble human insulin following subcutaneous administration in nine children (aged 6–12 years) and nine adolescents (aged 13–17 years) with stable type 1 diabetes. The study had a randomised, double-blind, two-period crossover design. Each patient received a single subcutaneous dose of insulin aspart or human insulin (0.15 IU/kg body weight) 5 min before breakfast and the plasma insulin and glucose concentrations were measured at intervals during the following 5 h. The pharmacokinetic profile of insulin aspart differed significantly from that of human insulin with a higher mean maximum serum insulin (Cmax ins), 881 ± 321 (SD) pmol/l versus 422 ± 193 pmol/l for human insulin (P < 0.001); and with a shorter median serum insulin tmax ins, 40.0 min (interquartile range: 40–50 min) versus 75.0 min (interquartile range: 60–120 min) for human insulin, (P < 0.001). An age-related effect on Cmax ins and area under the curve (AUC0–5h ins) was observed with higher values in adolescents than in children for both insulin aspart and human insulin. Postprandial glycaemic control was improved with insulin aspart; the baseline-adjusted ΔCmax glu being lower for insulin aspart compared with human insulin (increase of 7.6 ± 5.1 versus 9.4 ± 4.4 mmol/l respectively, P < 0.05). The incidence of adverse events was similar for the two insulin types. Conclusion The more rapid onset of action of insulin aspart versus human insulin, previously observed in adults, is confirmed in a paediatric population with type 1 diabetes.Keywords
This publication has 11 references indexed in Scilit:
- Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.Diabetes Care, 1999
- Insulin analogs with improved pharmacokinetic profilesAdvanced Drug Delivery Reviews, 1999
- Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.Diabetes Care, 1998
- Insulin management and metabolic control of Type 1 diabetes mellitus in childhood and adolescence in 18 countriesDiabetic Medicine, 1998
- Diabetic retinopathy in pediatric patients with type-1 diabetes: Effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic controlThe Journal of Pediatrics, 1998
- Diabetic angiopathy in childrenDiabetic Medicine, 1997
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.BMJ, 1985
- Roles of site and timing of the morning insulin injection in type 1 diabetesThe Journal of Pediatrics, 1983
- BLOOD PRESSURE IN DANISH CHILDREN and ADOLESCENTSActa Paediatrica, 1981